Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1969 Apr;62(4):317–318. doi: 10.1177/003591576906200402

Effects of drugs on placental function and their relation to congenital abnormalities.

J Davies, J M Robson, F M Sullivan
PMCID: PMC1810697  PMID: 4309465

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERGER M., CAVANAGH D. TOXEMIA OF PREGNANCY. THE HYPERTENSIVE EFFECT OF ACUTE EXPERIMENTAL PLACENTAL ISCHEMIA. Am J Obstet Gynecol. 1963 Oct 1;87:293–305. [PubMed] [Google Scholar]
  2. BROWNE F. J. Aetiology of pre-eclamptic toxaemia and eclampsia; fact and theory. Lancet. 1958 Jan 18;1(7012):115–119. doi: 10.1016/s0140-6736(58)90609-3. [DOI] [PubMed] [Google Scholar]
  3. Charvát J., Holecek V. Studies on antidiuretic hormone. Acta Med Acad Sci Hung. 1966;23(1):81–93. [PubMed] [Google Scholar]
  4. Gomel V., Hardwick D. F. Search for a pressor substance in toxemia of pregnancy. Am J Obstet Gynecol. 1966 Feb 1;94(3):308–309. doi: 10.1016/0002-9378(66)90649-1. [DOI] [PubMed] [Google Scholar]
  5. HUNTER C. A., Jr, HOWARD W. F. Etiology of hypertension in toxemia of pregnancy. Am J Obstet Gynecol. 1961 Mar;81:441–450. doi: 10.1016/s0002-9378(15)33660-7. [DOI] [PubMed] [Google Scholar]
  6. Hodari A. A. Chronic uterine ischemia and reversible experimental "toxemia of pregnancy". Am J Obstet Gynecol. 1967 Mar 1;97(5):597–607. doi: 10.1016/0002-9378(67)90448-6. [DOI] [PubMed] [Google Scholar]
  7. Honey D. P., Robson J. M., Sullivan F. M. Mechanism of inhibitory action of 5-hydroxytryptamine on placental function. Am J Obstet Gynecol. 1967 Sep 15;99(2):250–257. doi: 10.1016/0002-9378(67)90328-6. [DOI] [PubMed] [Google Scholar]
  8. Josephides E. C., Turkington V. E. Serum cystine aminopeptidase "oxytocinase" as an index of placental function. J Obstet Gynaecol Br Commonw. 1967 Apr;74(2):258–261. doi: 10.1111/j.1471-0528.1967.tb14870.x. [DOI] [PubMed] [Google Scholar]
  9. Marley P. B., Robson J. M., Sullivan F. M. Embryotoxic and teratogenic action of 5-hydroxytryptamine: mechanism of action in the rat. Br J Pharmacol Chemother. 1967 Nov;31(3):494–505. doi: 10.1111/j.1476-5381.1967.tb00414.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PATERSON M. L. The role of the posterior pituitary antidiuretic hormone in toxaemia of pregnancy. J Obstet Gynaecol Br Emp. 1960 Dec;67:883–898. doi: 10.1111/j.1471-0528.1960.tb09242.x. [DOI] [PubMed] [Google Scholar]
  11. POULSON E., ROBSON J. M., SULLIVAN F. M. Teratogenic effect of 5-hydroxytryptamine in mice. Science. 1963 Aug 23;141(3582):717–718. doi: 10.1126/science.141.3582.717. [DOI] [PubMed] [Google Scholar]
  12. REDDY D. V., ADAMS F. H., BAIRD C. TERATOGENIC EFFECTS OF SEROTONIN. J Pediatr. 1963 Sep;63:394–397. doi: 10.1016/s0022-3476(63)80425-4. [DOI] [PubMed] [Google Scholar]
  13. ROBSON J. M., SULLIVAN F. M. Mechanism of lethal action of 5-hydroxytryptamine on the foetus. J Endocrinol. 1963 Jan;25:553–554. doi: 10.1677/joe.0.0250553. [DOI] [PubMed] [Google Scholar]
  14. Southgate J., Sandler M. 5-hydroxyindole metabolism in pregnancy. Adv Pharmacol. 1968;6(Pt B):179–186. doi: 10.1016/s1054-3589(08)60313-0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES